List of Excipients in API GABAPENTIN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing GABAPENTIN
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | FD&C BLUE NO. 2 | |
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | GELATIN | |
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | LACTOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing GABAPENTIN
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 | CALCIUM STEARATE |
| Actavis Pharma Inc | gabapentin | 0228-2636 | CROSPOVIDONE |
| Actavis Pharma Inc | gabapentin | 0228-2636 | FD&C BLUE NO. 2--ALUMINUM LAKE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for GABAPENTIN
Excipient focus: 1,3-PROPANEDIOL BIS(4-AMINOBENZOATE)
GABAPENTIN drug variants containing 1,3-PROPANEDIOL BIS(4-AMINOBENZOATE)
| Company | Ingredient | NDC |
|---|---|---|
| Cardinal Health 107 LLC | gabapentin | 55154-8194 |
| American Health Packaging | gabapentin | 60687-580 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing 1,3-PROPANEDIOL BIS(4-AMINOBENZOATE)
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACESULFAME POTASSIUM
GABAPENTIN drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0698 |
| Amneal Pharmaceuticals LLC | gabapentin | 65162-698 |
| Advagen Pharma Ltd | gabapentin | 72888-104 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACETIC ACID
GABAPENTIN drug variants containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | gabapentin | 17856-0311 |
| Atlantic Biologicals Corps | gabapentin | 17856-1311 |
| BioComp Pharma Inc | gabapentin | 44523-120 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
GABAPENTIN drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | gabapentin | 10135-644 |
| Blenheim Pharmacal Inc | gabapentin | 10544-436 |
| Rebel Distributors Corp | gabapentin | 21695-055 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM HYDROXIDE
GABAPENTIN drug variants containing ALUMINUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 45963-555 |
| A-S Medication Solutions | gabapentin | 50090-2561 |
| A-S Medication Solutions | gabapentin | 50090-3318 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing ALUMINUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
GABAPENTIN drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | gabapentin | 10135-644 |
| Blenheim Pharmacal Inc | gabapentin | 10544-436 |
| Rising Pharma Holdings Inc | gabapentin | 16571-867 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
GABAPENTIN drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | gabapentin | 0904-6665 |
| NorthStar RxLLC | gabapentin | 16714-503 |
| QPharma Inc | gabapentin | 42708-056 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANISE
GABAPENTIN drug variants containing ANISE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing ANISE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: BROWN IRON OXIDE
GABAPENTIN drug variants containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sterling Knight PharmaceuticalsLLC | gabapentin | 69336-106 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
GABAPENTIN drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | gabapentin | 10135-644 |
| Blenheim Pharmacal Inc | gabapentin | 10544-436 |
| Rising Pharma Holdings Inc | gabapentin | 16571-867 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM CARBONATE
GABAPENTIN drug variants containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutica North America Inc | gabapentin | 45861-111 |
| Direct Rx | gabapentin | 61919-102 |
| Direct Rx | gabapentin | 61919-492 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM STEARATE
GABAPENTIN drug variants containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6554 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM SULFATE DIHYDRATE
GABAPENTIN drug variants containing CALCIUM SULFATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutica North America Inc | gabapentin | 45861-111 |
| Direct Rx | gabapentin | 61919-102 |
| Direct Rx | gabapentin | 61919-492 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing CALCIUM SULFATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
GABAPENTIN drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0698 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| Amneal Pharmaceuticals LLC | gabapentin | 65162-698 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
GABAPENTIN drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | gabapentin | 0904-6823 |
| Assertio Therapeutics Inc | gabapentin | 13913-004 |
| NorthStar Rx LLC | gabapentin | 16714-330 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77891
GABAPENTIN drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | gabapentin | 50090-7388 |
| A-S Medication Solutions | gabapentin | 50090-7389 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE
GABAPENTIN drug variants containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8019 |
| Marlex Pharmaceuticals Inc | gabapentin | 10135-647 |
| Atlantic Biologicals Corps | gabapentin | 17856-0135 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
GABAPENTIN drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8098 |
| NCS HealthCare of KY LLC dba Vangard Labs | gabapentin | 0615-8132 |
| NCS HealthCare of KY LLC dba Vangard Labs | gabapentin | 0615-8233 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
GABAPENTIN drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | gabapentin | 10544-436 |
| Rebel Distributors Corp | gabapentin | 21695-055 |
| A-S Medication Solutions | gabapentin | 50090-2590 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
GABAPENTIN drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
GABAPENTIN drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | gabapentin | 68071-3527 |
| REMEDYREPACK INC | gabapentin | 70518-3140 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
GABAPENTIN drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7844 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
GABAPENTIN drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 45963-555 |
| Unit Dose Services | gabapentin | 50436-5550 |
| RPK Pharmaceuticals Inc | gabapentin | 53002-3423 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEHYDRATED ALCOHOL
GABAPENTIN drug variants containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | gabapentin | 16571-867 |
| Method Pharmaceuticals LLC | gabapentin | 58657-720 |
| Graviti Pharmaceuticals Private Limited | gabapentin | 69844-055 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
GABAPENTIN drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | gabapentin enacarbil | 53451-0103 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
GABAPENTIN drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7844 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
GABAPENTIN drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | gabapentin | 16571-867 |
| MARKSANS PHARMA LIMITED | gabapentin | 25000-103 |
| Actavis Pharma Inc | gabapentin | 45963-555 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
GABAPENTIN drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6554 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
GABAPENTIN drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Actavis Pharma Inc | gabapentin | 45963-555 |
| Unit Dose Services | gabapentin | 50436-5550 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
GABAPENTIN drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| MedVantx Inc | gabapentin | 66116-444 |
| Bryant Ranch Prepack | gabapentin | 71335-2381 |
| Bryant Ranch Prepack | gabapentin | 71335-2478 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
GABAPENTIN drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7844 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
GABAPENTIN drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | gabapentin | 16590-492 |
| MedVantx Inc | gabapentin | 66116-444 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
GABAPENTIN drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7844 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
GABAPENTIN drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6554 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
GABAPENTIN drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6554 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
GABAPENTIN drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
GABAPENTIN drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | gabapentin | 17856-0311 |
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0600 |
| Atlantic Biologicals Corps | gabapentin | 17856-1311 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL BEHENATE
GABAPENTIN drug variants containing GLYCERYL BEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | gabapentin | 16590-104 |
| Rebel Distributors Corp | gabapentin | 21695-058 |
| Pharmaceutica North America Inc | gabapentin | 45861-111 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing GLYCERYL BEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL DIBEHENATE
GABAPENTIN drug variants containing GLYCERYL DIBEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-166 |
| Ascent Pharmaceuticals Inc | gabapentin | 43602-466 |
| A-S Medication Solutions | gabapentin | 50090-6189 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing GLYCERYL DIBEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
GABAPENTIN drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0600 |
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0698 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
GABAPENTIN drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
GABAPENTIN drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | gabapentin | 16590-104 |
| Rebel Distributors Corp | gabapentin | 21695-058 |
| PD-Rx Pharmaceuticals Inc | gabapentin | 43063-611 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
GABAPENTIN drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY LLC dba Vangard Labs | gabapentin | 0615-8132 |
| NCS HealthCare of KY LLC dba Vangard Labs | gabapentin | 0615-8233 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
GABAPENTIN drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
GABAPENTIN drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
GABAPENTIN drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6554 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8019 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
GABAPENTIN drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | gabapentin | 10135-644 |
| Blenheim Pharmacal Inc | gabapentin | 10544-436 |
| Rising Pharma Holdings Inc | gabapentin | 16571-867 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
GABAPENTIN drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| STAT RX USA LLC | gabapentin | 16590-870 |
| Viatris Specialty LLC | gabapentin | 58151-281 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
GABAPENTIN drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | gabapentin | 25000-103 |
| MSM Repackaging | gabapentin | 42495-266 |
| STAT Rx USA LLC | gabapentin | 42549-537 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
GABAPENTIN drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | gabapentin | 13913-004 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Almatica Pharma LLC | gabapentin | 52427-803 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
GABAPENTIN drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | gabapentin | 50090-3912 |
| A-S Medication Solutions | gabapentin | 50090-3915 |
| Unit Dose Services | gabapentin | 50436-3011 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
GABAPENTIN drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8019 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8098 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
GABAPENTIN drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
GABAPENTIN drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| Advagen Pharma Ltd | gabapentin | 72888-104 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: N-BUTYL ALCOHOL
GABAPENTIN drug variants containing N-BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | gabapentin | 50090-7388 |
| A-S Medication Solutions | gabapentin | 50090-7389 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing N-BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
GABAPENTIN drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8019 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8098 |
| NCS HealthCare of KY LLC dba Vangard Labs | gabapentin | 0615-8132 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
GABAPENTIN drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8098 |
| NCS HealthCare of KY LLC dba Vangard Labs | gabapentin | 0615-8132 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
GABAPENTIN drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | gabapentin | 13913-004 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Laurus Labs Limited | gabapentin | 42385-979 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
GABAPENTIN drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | gabapentin | 16590-104 |
| Rebel Distributors Corp | gabapentin | 21695-058 |
| Unit Dose Services | gabapentin | 50436-3011 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
GABAPENTIN drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 7000000
GABAPENTIN drug variants containing POLYETHYLENE GLYCOL 7000000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYETHYLENE GLYCOL 7000000
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
GABAPENTIN drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | gabapentin | 50436-7286 |
| Lupin Pharmaceuticals Inc | gabapentin | 68180-348 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
GABAPENTIN drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6554 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
GABAPENTIN drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8019 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8098 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
GABAPENTIN drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | gabapentin | 13913-004 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Laurus Labs Limited | gabapentin | 42385-979 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
GABAPENTIN drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | gabapentin | 10135-644 |
| Blenheim Pharmacal Inc | gabapentin | 10544-436 |
| Rebel Distributors Corp | gabapentin | 21695-055 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
GABAPENTIN drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0698 |
| Amneal Pharmaceuticals LLC | gabapentin | 65162-698 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
GABAPENTIN drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | gabapentin | 43063-611 |
| A-S Medication Solutions | gabapentin | 50090-3912 |
| A-S Medication Solutions | gabapentin | 50090-3915 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
GABAPENTIN drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
GABAPENTIN drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7844 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
GABAPENTIN drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| Advagen Pharma Ltd | gabapentin | 72888-104 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
GABAPENTIN drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | gabapentin | 72888-104 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
GABAPENTIN drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7844 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7961 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
GABAPENTIN drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7844 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
GABAPENTIN drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | gabapentin | 17856-0311 |
| Atlantic Biologicals Corps | gabapentin | 17856-1311 |
| BioComp Pharma Inc | gabapentin | 44523-120 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
GABAPENTIN drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0600 |
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0698 |
| Acella Pharmaceuticals LLC | gabapentin | 42192-608 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
GABAPENTIN drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7844 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
GABAPENTIN drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-7762 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
GABAPENTIN drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sterling Knight PharmaceuticalsLLC | gabapentin | 69336-106 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: STRAWBERRY
GABAPENTIN drug variants containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
GABAPENTIN drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-1378 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6554 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
GABAPENTIN drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | gabapentin | 0904-6823 |
| Rising Pharma Holdings Inc | gabapentin | 16571-116 |
| Rising Pharma Holdings Inc | gabapentin | 16571-226 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
GABAPENTIN drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8019 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-8098 |
| NCS HealthCare of KY LLC dba Vangard Labs | gabapentin | 0615-8132 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Excipient focus: XYLITOL
GABAPENTIN drug variants containing XYLITOL
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | gabapentin | 17856-0311 |
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0600 |
| Atlantic Biologicals Corps | gabapentin | 17856-1311 |
| >Company | >Ingredient | >NDC |
GABAPENTIN drug variants not containing XYLITOL
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
